THE GENITAL PSORIASIS WELLNESS CONSORTIUM Trademark

Trademark Overview


On Monday, January 22, 2024, a trademark application was filed for THE GENITAL PSORIASIS WELLNESS CONSORTIUM with the United States Patent and Trademark Office. The USPTO has given the THE GENITAL PSORIASIS WELLNESS CONSORTIUM trademark a serial number of 98369437. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, November 12, 2024. This trademark is owned by Arcutis Biotherapeutics, Inc.. The THE GENITAL PSORIASIS WELLNESS CONSORTIUM trademark is filed in the Advertising, Business and Retail Services and Education & Entertainment Services categories with the following description:

Providing educational services to healthcare providers and patients, namely, providing presentations, seminars, webinars, workshops, publications, posters, pamphlets, brochures, videos, commercials, newsletters and information via emails, social media content, tradeshow materials, product theaters, and healthcare professional promotional materials in the field of disease diagnosis and disease management

Promoting public interest and awareness of autoimmune conditions by means of public advocacy
the genital psoriasis wellness consortium

General Information


Serial Number98369437
Word MarkTHE GENITAL PSORIASIS WELLNESS CONSORTIUM
Filing DateMonday, January 22, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding educational services to healthcare providers and patients, namely, providing presentations, seminars, webinars, workshops, publications, posters, pamphlets, brochures, videos, commercials, newsletters and information via emails, social media content, tradeshow materials, product theaters, and healthcare professional promotional materials in the field of disease diagnosis and disease management
Description of MarkThe mark consists of the stylized black wording "The Genital Psoriasis" stacked on top of the stylized black wording "Wellness Consortium". There are five yellow dots with black drop shadow in the shape of a plus sign to the upper right of the words "The Genital Psoriasis". The color white is not a claimed feature of the mark and represents background.
Indication of Colors claimedThe color(s) yellow and black is/are claimed as a feature of the mark.
Goods and ServicesPromoting public interest and awareness of autoimmune conditions by means of public advocacy
NOT AVAILABLE"THE GENITAL PSORIASIS WELLNESS CONSORTIUM"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameArcutis Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91361

Trademark Events


Event DateEvent Description
Monday, January 22, 2024NEW APPLICATION ENTERED
Wednesday, May 22, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 16, 2024ASSIGNED TO EXAMINER
Tuesday, August 20, 2024NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 20, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 20, 2024NON-FINAL ACTION WRITTEN